TrialMolecular medicine reports2018

Effects of isomaltulose on insulin resistance and metabolites in patients with non‑alcoholic fatty liver disease: A metabolomic analysis.

Takumi Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.